Skip to main content
. 2019 Jun 17;16(1):74–89. doi: 10.1007/s11481-019-09858-x

Fig. 2.

Fig. 2

Alterations of BBB functionality as the result of exposure to antiretroviral drugs. Alterations (red arrow: decrease; green arrow: increase) of cellular processes at the level of the BBB resulting from exposure to antiretroviral drugs. (LPV: lopinavir; EFV: efavirenz; SQV: saquinavir; ATV: ataznavir; RTV: ritonavir; ZDV: zidovudine; IDV: indinavir; TDF: tenofovir; FTC: emtricitabine; MVC: maraviroc; RAL: raltegravir; DRV: darunavir)